{"brief_title": "Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers", "brief_summary": "The purpose of this study is to see if it is safe to give GENEVAX-HIV, a new HIV vaccine, to HIV-negative volunteers. This study will also look at how this vaccine affects the immune system of these volunteers.", "detailed_description": "In this open-label study, volunteers are given an intramuscular injection of GENEVAX-HIV vaccine using the Biojector 2000. Safety measures and immune response are assessed accordingly.", "condition": "HIV Seronegativity", "intervention_type": "Biological", "intervention_name": "APL 400-003", "criteria": "Inclusion Criteria You may be eligible for this study if you: - Are 18 - 60 years old. - Are HIV-negative and in good health. - Are able to understand how infections such as HIV are spread. - Agree to use effective methods of birth control during the study. Exclusion Criteria You will not be eligible for this study if you: - Have hepatitis B or C. - Have any condition that may prevent you from completing the study. - Are allergic to bupivacaine, vaccines, or certain local anesthetics. - Have taken certain medications or have received certain therapies that may affect your immune system. - Have an immune system disorder or have received therapy for an immune system disorder. - Have been exposed to HIV within 6 months prior to study entry. - Have received an experimental HIV vaccine or any other experimental treatment within 30 days prior to study entry. - Have received blood transfusions within 6 months prior to study entry. - Abuse alcohol or drugs or have an uncontrolled psychiatric disorder. - Are pregnant or breast-feeding.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "60 Years", "healthy_volunteers": "Accepts Healthy Volunteers", "id": "NCT00002231.xml"}